BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21696508)

  • 1. Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Kikuchi Y; Kashii Y; Gunji Y; Morimoto A; Masuzawa A; Takatsuka Y; Fujita E; Komine M; Ohtsuki M; Matsubara D; Kobayashi C; Sakurai A; Yanase K; Kato K; Koike K; Tsuchida M; Momoi MY
    Pediatr Int; 2011 Jun; 53(3):393-6. PubMed ID: 21696508
    [No Abstract]   [Full Text] [Related]  

  • 2. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
    Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
    Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Cutaneous Aggressive Epidermotropic CD8+ T-cell Lymphoma with Brain Involvement and Mimicking Dermatomyositis.
    Terui H; Yamasaki K; Yoshida S; Aiba S
    Acta Derm Venereol; 2018 Jan; 98(1):128-129. PubMed ID: 28597026
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome.
    Le Loarer F; Barete S; Vallat L; Carre D; El Amarti R; Torres-Cabala C; Cacoub P; Sene D; Courville P; Bravard P
    Acta Derm Venereol; 2014 May; 94(3):317-9. PubMed ID: 23995595
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.
    Lee J; Yang YJ; Kim JI; Park JH; Kim WS
    Indian J Ophthalmol; 2015 Jan; 63(1):81-2. PubMed ID: 25686076
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma, ear-type: a unique cutaneous T-cell lymphoma with a favourable prognosis.
    Géraud C; Goerdt S; Klemke CD
    Br J Dermatol; 2011 Feb; 164(2):456-8. PubMed ID: 20969565
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
    Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
    Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
    Kim SK; Kim YC; Kang HY
    J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
    Kasuya A; Hirakawa S; Tokura Y
    Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8(+) aggressive lymphoma in a human T-cell leukaemia virus type-1 carrier.
    Saigusa R; Sugaya M; Sunaga S; Sumida H; Suga H; Fujita H; Yoshimii A; Sunaga S; Sato S
    J Dermatol; 2014 May; 41(5):443-4. PubMed ID: 24801919
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in a human T-cell leukaemia virus type-1 carrier.
    Ohmatsu H; Sugaya M; Fujita H; Miyagaki T; Kadono T; Maeda D; Takazawa Y; Fukayama M; Tamaki K; Sato S
    Acta Derm Venereol; 2010 May; 90(3):324-5. PubMed ID: 20526566
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.
    Jacks SM; Taylor BR; Rogers RP; Ralston JS; Metcalf JS; Lazarchick J
    J Am Acad Dermatol; 2014 Sep; 71(3):e86-7. PubMed ID: 25128139
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
    Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
    Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case].
    Intriago B M; Peña O C; Gray H AM; Cabrera C ME; Martínez C V
    Rev Med Chil; 2012 Mar; 140(3):368-72. PubMed ID: 22689119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8
    Deenen NJ; Koens L; Jaspars EH; Vermeer MH; Willemze R; de Rie MA; Bekkenk MW
    Br J Dermatol; 2019 Feb; 180(2):411-412. PubMed ID: 30259963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.